Drug
Azithromycin Monohydrate Geneva Pharmaceuticals
Azithromycin Monohydrate Geneva Pharmaceuticals: highest development phase Phase 1, developed by Sandoz. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sandoz
Trials
| Drug | Phase | Indication |
|---|---|---|
| Azithromycin Monohydrate 600mg Tablets Geneva Pharmaceuticals NCT00866216 | Phase 1 | Infection |
Latest
No recent events.
Follow Azithromycin Monohydrate Geneva Pharmaceuticals on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.